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Abstract
Background: Evidence suggests that increased preoperative alcohol consumption increases the risk of
postoperative complications; therefore, a reduction or cessation in alcohol intake before surgery may reduce
perioperative risk. Preoperative assessment presents an opportunity to intervene to optimise patients for surgery.
This multicentre, two-arm, parallel group, individually randomised controlled trial will investigate whether a
definitive trial of a brief behavioural intervention aimed at reducing preoperative alcohol consumption is feasible
and acceptable to healthcare professionals responsible for its delivery and the preoperative elective orthopaedic
patient population.
Methods: Screening will be conducted by trained healthcare professionals at three hospitals in the North East of
England. Eligible patients (those aged 18 or over, listed for elective hip or knee arthroplasty surgery and scoring 5
or more or reporting consumption of six or more units on a single occasion at least weekly on the alcohol
screening tool) who enrol in the trial will be randomised on a one-to-one non-blinded basis to either treatment as
usual or brief behavioural intervention delivered in the pre-assessment clinic. Patients will be followed up 1–2 days
pre-surgery, 1–5 days post-surgery (as an in-patient), 6 weeks post-surgery, and 6 months post intervention.
Feasibility will be assessed through rates of screening, eligibility, recruitment, and retention to 6-month follow-up.
An embedded qualitative study will explore the acceptability of study methods to patients and staff.
Discussion: This pilot randomised controlled trial will establish the feasibility and acceptability of trial procedures
reducing uncertainties ahead of a definitive randomised controlled trial to establish the effectiveness of brief
behavioural intervention to reduce alcohol consumption in the preoperative period and the potential impact on
perioperative complications.
Trial registration: Reference number ISRCTN36257982
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Background
Preoperative alcohol consumption increases the risk of
postoperative complications following major surgery [1, 2]
and specifically orthopaedic surgery [3, 4]. Postoperative
complications are associated with increased length of hos-
pital stay, delayed patient recovery, reduced well-being [5]
and a two- to threefold increase in hospital costs [6].
Even minor postoperative complications reduce func-
tional independence [7] and cause significant decrease
in longevity [5, 8].
In the elective orthopaedic surgical population, average
rates of mortality and morbidity following primary total
hip and knee replacement are 0.2–0.6% [9–11] and 4–6%
respectively [9, 12]. In terms of major surgery, these rates
are relatively low. However, primary arthroplasty already
represents a high volume type of major surgery [13]. As
life expectancy continues to increase worldwide [14], both
the shift in ageing demographics and the natural history
of arthritic disease will inevitably lead to a greater number
of older patients undergoing major elective orthopaedic
surgery. With advancing age also comes an increase in the
number of significant comorbidities [15]. This combin-
ation of high-volume surgery in an ever-increasing popu-
lation of older patients with multiple comorbidities is a
potent risk for an increase in postoperative complications
[16, 17] and will become a major public health burden
[18] if specific interventions to reduce perioperative risk
are not developed.
‘Prehabilitation’ refers to a group of interventions,
integrated into the clinical pathway before a proposed
surgical procedure, aimed at both reducing imminent
patient risk and promoting lasting beneficial effects
on perioperative recovery and outcome. The benefits
of preoperative anaemia correction, collaborative deci-
sion making [19], multimodal pulmonary training re-
gimes, improving nutrition while encouraging physical
activity, and promoting structured exercise regimes
are improving patient outcomes [20–26]. Lifestyle
modification is a key component of the value propos-
ition for perioperative care [27]. Alongside smoking
cessation [28] alcohol reduction prior to surgery is an
important prehabilitative goal.
Among patients undergoing total hip or knee arthro-
plasty, those identified as having alcohol misuse showed
significantly higher incidences of 12 out of 15 complica-
tions assessed [29] with an overall complication rate of
33.5% among alcohol misusers compared to 22.6% in their
non-alcohol misusing counterparts. This population were
also found to have significantly longer stays in hospital
[29]. Further to this, a study of men undergoing total joint
arthroplasty reports a 29% increase in the number of com-
plications for every additional point on the Alcohol Use
Disorders Identification Tool (AUDIT) screening tool [3].
Therefore, cessation or even reduction in alcohol intake
before surgery may reduce perioperative risk [3, 30] and
could have public health benefit if behaviour change con-
tinues post operatively. Alcohol screening using validated
screening tools has been shown to have good patient
acceptance [3, 30–33]. In addition, where a dedicated
screening tool (AUDIT) [34]) has been used in the
European preoperative setting [35], there was an increased
detection rate of preoperative alcohol use when compared
with clinician assessment. However, in general, these
methods have not been introduced into UK elective
surgical pathways.
Good quality evidence exists for the effective delivery
of brief behavioural interventions for the reduction of
alcohol intake in primary care [36–39], with those who
received brief intervention reporting lower weekly alcohol
consumption compared to control participants (mean dif-
ference − 20 g, 95% confidence intervals (CI) − 28 to − 12)
[38]. Evidence for the effectiveness of such interventions
in emergency departments [40, 41] and hospital wards
[42] is also rapidly growing. In perioperative care, Rosen-
berg et al. [41] reported reduced drinking and fewer post-
operative complications among alcohol dependent
patients who withdrew from alcohol consumption and
remained abstinent supported by disulfiram therapy in the
month before surgery compared to those who received
treatment as usual. Further to this, a meta-analysis [1] of
preoperative interventions including pharmacological
components found a significant reduction in complication
rates (odds ratio (OR) 0.22, (CI) 0.08 to 0.61, P = 0.04).
However, less evidence exists regarding the effectiveness
of behavioural interventions to reduce alcohol consump-
tion before surgery [1] and findings from such studies are
mixed. Specifically, in unpublished data, cited in a
Cochrane review [1], Tonnesen et al. reported that inten-
sive motivational counselling, delivered as weekly brief
interviews and supported by disulfiram therapy, aimed at
3 months of preoperative alcohol cessation, reduced alco-
hol consumption in all patients in the intervention group.
In contrast, Shourie et al. [43] showed no effect on drink-
ing outcomes of a brief behavioural intervention. The
discrepancies in findings between these two trials may be
due to methodological differences, including the utilisa-
tion of both pharmacological and behavioural interven-
tions and length and intensity of the interventions.
Tonneson and colleagues [1] employed a more in-depth
intervention delivered over a 3-month period before sur-
gery while Shourie and colleagues [43] employed a brief
intervention with preoperative review restricted to < 7 days
before operation, a factor which the authors subsequently
quoted as the major reason for intervention failure. With
such variation in findings, more evidence regarding the
effectiveness of behavioural interventions to reduce alco-
hol consumption in the preoperative period is required.
Future trials should aim to deliver intentions with greater
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than 7 days for the implementation of behaviour change,
something which this pilot randomised controlled trial
(RCT) will aim to achieve by delivering interventions at
the preoperative assessment appointment.
With previous trials having been conducted outside of
the UK and findings from these trials being inconclusive,
it is considered important to optimise intervention and
research methods and assess the feasibility of conducting
a full RCT which would then assess the effectiveness of
behavioural interventions to reduce alcohol consump-
tion in the preoperative period. Initial feasibility work
was conducted at one centre between April 2016 and
February 2017 with the aim of optimising the training,
screening and intervention techniques prior to the larger
multicentre pilot RCT. As such, the feasibility study did
not include randomisation or follow-up assessments. A
group training session covering the delivery of alcohol
screening and brief behavioural intervention was pro-
vided to healthcare professionals (HCPs) employed in
preoperative assessment. Screening (using the AUDIT
C) and recruitment of eligible patients was then con-
ducted with recruited patients completing the full
AUDIT and receiving the behavioural intervention. Fi-
nally, qualitative interviews were conducted with HCPs
and patients to explore the acceptability of the proposed
brief intervention and training methods, patient partici-
pants were also presented with copies of the proposed
pilot RCT follow-up questionnaires and asked to provide
their opinion on these. A total of nine HCPs consented
to be involved in the study with four going on to deliver
interventions. Subsequent screening data reveal approxi-
mately 29% of patients listed for elective hip or knee
arthroplasty score ≥ 5 on the AUDIT C and almost 16%
report consumption of six or more standard drinks on a
single occasion at least weekly. Fifteen patients were re-
cruited to the study. Intervention sessions were recorded
and assessed for fidelity of delivery with feedback pro-
vided to the HCPs. This work identified and addressed
some implementation issues, detailed in the “Discussion”
section. Follow-up interviews (HCPs n = 3; patients n = 11)
found that proposed screening and intervention techniques
(i.e. behaviour change and brief motivational techniques)
were acceptable to both patients and healthcare profes-
sionals delivering the intervention. Further to this, screen-
ing and intervention could be conducted without
impacting negatively on patient care. Focus groups (N = 3)
conducted with HCPs (N = 19) from across the three
centres established the characteristics of treatment as usual
in preoperative assessment. Fidelity assessments and HCP
interviews were utilised to optimise the training ahead of
the pilot RCT. This pilot randomised controlled trial
(RCT) aims to assess the feasibility and acceptability
of HCP-delivered structured alcohol screening followed
by brief behavioural intervention in the preoperative
assessment clinic for patients undergoing primary elective
hip or knee arthroplasty. Specifically, rates of recruit to a
randomised trial of the brief behavioural intervention,
retention rates at 6-month follow-up and completion rates
for outcome measures will be assessed.
Methods/design
Design
A multicentre, two-arm (treatment as usual (TAU) vs
brief behavioural intervention), parallel group, individu-
ally randomised controlled trial is used. A summary of
the trial is displayed in Table 1.
Aim
The primary aim of this pilot RCT is:
To estimate rates of patient eligibility, recruitment and
retention at 6 months post-assessment in order to assess
the feasibility of proceeding to a definitive RCT.
The secondary objectives are:
– To train healthcare professionals (HCPs) in the
delivery of structured screening and brief
behavioural intervention to eligible patients in the
preoperative assessment setting.
– To assess completion rates for all data collection
tools including measures of alcohol consumption,
quality of life and joint functionality.
– To establish response variability of proposed
outcome measures for a definitive trial, which will
include drinking status and quality of life
– To estimate rates of secondary outcomes and
perioperative complication rates including bleeding
and infections
– To explore the acceptability of intervention and
research methods with HCPs and patients through
qualitative interviews.
While this pilot RCT is primarily concerned with re-
cruitment and retention, a definitive RCT would have
the primary objective of evaluating the effectiveness of
brief behavioural intervention in reducing perioperative
alcohol consumption. Secondary objectives would in-
clude assessing any resultant changes in secondary out-
comes of alcohol perioperative complication rates and
quality of life as well as longer-term changes in alcohol
consumption at 6 months post intervention.
Setting
The RCT will be conducted across three secondary care
hospital clinics, in North East England, dedicated to pre-
operative assessment of patients before elective major
surgery. Each has an orthopaedic preoperative surgical
care pathway of 6 to 10 weeks from preoperative assess-
ment to surgery. Across the three sites, approximately
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30 HCPs are employed in the preoperative assessment
clinics and a combined total of approximately 4000 hip
or knee arthroplasties are conducted each year. Based
on AUDIT C screening results from the feasibility study,
this would provide a pool of approximately 1160 eligible
patients.
Participants—patients
The pilot trial will aim to recruit 80 (40 in each trial arm)
patients. Patient participants will be adults aged 18 years
and over, listed for elective primary hip or knee arthro-
plasty who screen positively for increased risk drinking
(AUDIT C score ≥ 5 or report consuming 6 units or more
in one session at least weekly) with the capacity to provide
informed written consent and able to write and converse
in English. Patients likely to undergo sequential joint re-
placements within the duration of the study, those display-
ing current (active) withdrawal from alcohol, those with
severe psychiatric disorder requiring medical treatment,
cognitive impairments or dementia impacting ability to
interact with the intervention will be excluded in this RCT.
Participants—healthcare professionals
Across the three sites, HCPs employed in the preopera-
tive assessment clinics will receive training on study pro-
cedures, screening patients using the AUDIT C tool and
completion of study baseline measures. In addition, a
subset of HCPs (minimum two per centre) will be
trained to deliver the brief behavioural intervention.
Table 1 Trial summary
Data category Information
Primary registry and trial
identifying number
ISRCTN36257982
Date of registration in
primary registry
06/01/2016
Secondary identifying numbers REC: 17/NE/0093
Funder Reference: 14/42/01
Source(s) of monetary or
material support
National Institute for Health Research
Health Technology Assessment
Primary sponsor Newcastle upon Tyne Hospitals NHS
Foundation Trust
Secondary sponsor(s) N/A
Contact for public queries Miss Nicola Goudie
Newcastle Clinical Trials Unit
Newcastle University
1–4 Claremont Terrace
Newcastle upon Tyne
NE2 4AE
United Kingdom
Contact for scientific queries Miss Nicola Goudie
Newcastle Clinical Trials Unit
Newcastle University
1–4 Claremont Terrace
Newcastle upon Tyne
NE2 4AE
United Kingdom
Public title Preoperative Behavioural Intervention
to Reduce Drinking before elective
orthopaedic Surgery
Scientific title Preoperative Behavioural Intervention
to Reduce Drinking before elective
orthopaedic Surgery
Countries of recruitment England
Health condition(s) or
problem(s) studied
Preoperative alcohol consumption
Intervention(s) Intervention: Preoperative Brief
Behavioural Intervention to reduce
or cease drinking in elective
orthopaedic patients
Comparator: Treatment as Usual
Key inclusion and
exclusion criteria
Ages eligible for study: ≥18 years
Sexes eligible for study: both
Accepts healthy volunteers: no
Inclusion criteria: adult patient
(≥ 18 years), listed for primary elective
joint (hip or knee) arthroplasty, AUDIT
C score ≥ 5 or report consuming 6
units or more in one session at least
weekly with the capacity to provide
informed written consent and able
to write and converse in English
Exclusion criteria: Patients likely
to undergo sequential joint
replacements within the duration
of the study, those displaying
current (active) withdrawal from
alcohol, those with severe psychiatric
disorder requiring medical treatment,
cognitive impairments or dementia
impacting ability to interact with the
intervention
Table 1 Trial summary (Continued)
Data category Information
Study type Interventional
Allocation: randomised (1:1)
Intervention model: parallel
assignment
Masking: non blinded
Date of first enrolment N/A
Target sample size 80
Recruitment status Recruitment to commence
June 2017
Primary outcome(s) Number of patients screened, and
the percentages of eligible patients
recruited and retained at 6-month
follow-up.
Key secondary outcomes Alcohol consumption: full AUDIT
score
Health Related Quality of Life:
The EQ-5D
Major and minor postoperative
complications: Clavien-Dindo
classification; Postoperative
Morbidity Survey (POMS)
Joint functionality: Western
Ontario and McMaster Universities
osteoarthritis index (WOMAC)
Functional Assessment score.
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The intervention is detailed in Table 2. The content
of the intervention materials have been defined in
terms of specific behaviour change techniques (BCTs)
that are the ‘active ingredients’ of the brief behav-
ioural intervention. Group training sessions, delivered
by the research associate (EL) and a health psycholo-
gist (LA), will be provided to HCPs at each hospital
site. Training will cover delivery of the intervention
including use of specific brief motivational techniques,
and each HCP will also receive a training manual to
support the formal training session. This training ap-
proach aims to equip HCPs with the knowledge and
skills they need to conduct screening with a validated
screening tool and deliver brief behavioural interven-
tions to motivate and support patients to either re-
duce their drinking to low-risk levels or abstain from
drinking in the perioperative period (the proposed ob-
jective for a definitive RCT).
Table 2 TIDieR description of intervention
Item Details Page
Name Preoperative Behavioural Intervention to Reduce Drinking before elective orthopaedic
Surgery (PRE-OP BIRDS)
1
Why Preoperative alcohol consumption is related to increased risk of postoperative complications.
The aim of the intervention is to support patients to reduce or cease alcohol consumption
prior to elective orthopaedic surgery.
7–11
What Materials:
Healthcare professionals (HCPs) are trained to screen for increased risk alcohol consumption
and to deliver the following intervention materials:
14
• Brief Advice Sheet
• Brief Intervention Sheet
• Patient Information Leaflet
17–19
Training also covers use of brief motivational techniques to increase motivation for change.
Training of healthcare
professionals is supported by a training manual.
Procedures: The intervention is delivered over two sessions (the second is optional). The first
session involves provision of 5 min of structured advice that aims to increase motivation
using the ‘brief advice sheet’. This is followed by 15–25 min of behaviour change intervention
using the brief intervention sheet. This intervention targets volitional aspects of behaviour
change. The aim of the second optional booster session is to review and/or revise behavioural
goals, provide feedback on performance and discuss self-monitoring to increase self-efficacy.
This session is also designed to allow those individuals who have showed an initial intention
to make changes, but who have not formally set behavioural goal(s) and plans to do so if desired.
17–19
Who provided HCPs employed in the Preoperative assessment clinics who have received training in the
delivery of screening and brief behavioural intervention.
14
How The initial intervention session is delivered face to face during routine clinics. The second
session, an optional booster session will be delivered either face to face in clinic or by
telephone depending upon patient preference. All intervention sessions are delivered one
to one.
17–19
Where Intervention sessions will be delivered during routine preoperative assessment clinics. Where
the patent opts to receive a booster session by telephone the HCP delivering the session
will call from the preoperative assessment clinic.
13
When and how much The first session involving delivery of brief advice and brief behavioural intervention will last
approximately 30 min and will be delivered during routine pre-assessment clinics once all
clinical procedures have been completed. The second optional, ‘booster’ session will last
approximately 20 min and will be delivered around 1 week before surgery.
17–19
Tailoring Intervention materials incorporate specific behaviour change techniques that target intention
formation and enactment of behaviour change (e.g. information on health consequences,
social support, goal setting behaviour, problem solving, restructuring the physical environment).
HCPs are trained to use these techniques to tailor the intervention to the needs and preferences
of the individual patient. For example, providing information relevant to and requested by the
patient and supporting them to set meaningful and realistic goals that fit in with their own
specific circumstances. Use of brief motivational techniques by HCPs allows them to determine
level of motivation to change and tailor the intervention to target motivation or volition at the
appropriate times.
17–19
How well Consultations with participating patients will be audio recorded to allow an assessment of skill
acquisition and fidelity of delivery of the intervention post-training. The aim is to improve fidelity
of delivery via provision of feedback to HCPs including aspects of intervention delivery that went
well and where they could improve. Feedback is provided following delivery of the intervention
by each HCP to patients 2 and 4.
14–15
26–27
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Each preoperative assessment HCP who has been
trained will aim to conduct a minimum of four patient
consultations where the intervention is delivered in
order to facilitate full engagement with intervention
delivery and allow feedback on fidelity of delivery. Audio
recordings will be made of all intervention sessions
where the patient provides consent. All recordings will
be transcribed verbatim before being deleted from the
recording device. All anonymised transcripts will be
assessed for fidelity of delivery by two members of the
research team (EL and LA) using a standardised check-
list of 18 BCTs and 5 behaviour change counselling
techniques. As the intervention is designed to allow tai-
lored delivery, assessors will first identify if each item
was appropriate before assessing if it was delivered.
Feedback (constructed by the research associate (EL)
and health psychologist (LA)) regarding skill acquisition
and fidelity of delivery will be provided to HCPs for the
second and fourth intervention sessions they deliver be-
fore any subsequent consultations where the interven-
tion is delivered take place. Where patients in sessions 2
and/or 4 do not consent to recording, fidelity of delivery
assessments will be conducted and feedback provided
for the next recorded session (where a patient does pro-
vide consent). If required (i.e. where fidelity of delivery
falls below the 80% threshold, based on the percentage
of items assessed as ‘appropriate’ that were identified as
delivered), the research associate (EL) will provide an
additional, one-to-one, face-to-face training session,
lasting up to 1 h to focus on components of the inter-
vention that were omitted when it may have been appro-
priate to deliver them.
Screening, consent and randomisation
The study process is shown in Fig. 1. Initial screening
for alcohol consumption using the AUDIT C will be
conducted either in the outpatient clinic or by telephone
following assessment and listing for elective orthopaedic
surgery. Screening will be performed by an HCP trained
in AUDIT C use and scoring. Screening will be con-
ducted in an appropriate environment offering the re-
quired privacy. The allocated HCP will complete the
AUDIT C with each patient listed for major joint arthro-
plasty. The AUDIT C score will be assessed immediately
for eligibility to the study.
Eligibility for the study will be confirmed if the elective
surgical patient screens positively for increasing risk
drinking (AUDIT C score ≥ 5) or reports at least weekly
drinking of 6 or more units in one session (as judged by
question 3 on AUDIT C). The trial will be discussed
with eligible patients and those that express an interest
in participating will be provided with a copy of the par-
ticipant information sheet. They will also be asked for
permission for the study team to contact them to discuss
the study further and their preferred method of contact.
Expressions of interest, contact information and pre-
ferred method of contact will be recorded in writing by
the HCP on the expression of interest form. The patient
will then be allowed time to consider their involvement
in the study (minimum 24 h). After this time, the site
will contact the patient to confirm positive expression of
ongoing interest. If the patient confirms they are still in-
terested, the pre-assessment clinic will be informed of
the patient’s likely participation to facilitate waiting list
and preoperative assessment clinic coordination for the
patient’s visit. Patients scoring AUDIT C < 5 will receive
positive feedback on their low-risk drinking status.
At the preoperative assessment clinic, a member of the
research team (not involved in screening or delivering
the intervention) will initially see the patient. The re-
searcher will check whether the patient is still interested
in participating in the study, and if so, the patient will be
asked to sign the informed consent form. Once consent
has been obtained, the researcher will access the New-
castle Clinical Trials Unit (NCTU) secure web-based
randomisation system where they will enter the patient’s
initials and date of birth. The randomisation system will
then allocate the patient to either the behavioural inter-
vention or treatment as usual groups on a 1:1 basis.
Allocations are built into the randomisation system as
part of study setup, and users accessing the system to
randomise have no control over the allocation. This trial
is not blinded.
Intervention
The brief behavioural intervention will be delivered over
two sessions—the first session which will take place in
the clinic will last approximately 30 min and will be de-
livered following pre-assessment in the pre-assessment
clinic. The second session, an optional booster session,
will be delivered over the phone or in the clinic
dependent on patient preference and will last approxi-
mately 20 min. This will be delivered approximately
1 week before surgery.
Following preoperative assessment, the patient and HCP
will complete the baseline assessments shown in Table 3
(full 10-item AUDIT [34], EQ-5D [44, 45], Western
Ontario and McMaster Universities Osteoarthritis Index
(WOMAC) [46]); the HCP will then deliver the first inter-
vention session. This session will provide participants with
5 min of simple, structured advice regarding alcohol con-
sumption including specific feedback on risk, normative
comparison, the benefits of reducing alcohol intake, strat-
egies that could be used to reduce drinking and a personal
target for reduced drinking (set by the patient). This com-
ponent of the intervention specifically targets motivation.
This will be followed by 15–25 min of behaviour change
intervention targeting alcohol reduction and cessation and
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specifically focuses on volition. Intervention materials in-
corporate specific behaviour change techniques that target
intention formation and enactment of behaviour change
(e.g. information on health consequences, social support,
goal setting behaviour, problem solving, restructuring the
physical environment). HCPs are trained to use these
techniques to tailor the intervention to the needs and
preferences of the individual patient, for example, provid-
ing information relevant to and requested by the patient
and supporting them to set meaningful and realistic goals
that fit in with their own specific circumstances. Use of
brief motivational techniques by HCPs allows them to
determine the level of motivation to change and tailor the
intervention to target motivation or volition at the appro-
priate times. Three intervention tools will be utilised:
 The Brief Advice (BA) tool will act as a visual aid for
communicating information and will provide
participating HCPs with prompts on how to structure
and deliver this advice to participating patients.
 The Brief Behaviour Change intervention (BI) tool will
be used by HCPs to guide discussion, goal setting and
problem solving with participating patients and to
record aspects of the intervention (e.g. goals and plans)
to prompt behaviour outside of the clinical setting.
 The Patient Information Leaflet, based on the
based on the Department of Health’s ‘Drinking
and you: How much is too much?’ booklet [47],
will be introduced and given to patients at the
end of the intervention session along with copies
of the BA and BI.
Fig. 1 Trial process diagram
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The BA and BI tools were based on the ‘How much is
too much?’ Simple Structured Advice, and Extended Brief
Intervention tools originally produced as part of the
World Health Organization collaborative study on alcohol
screening and brief intervention [48], before being adapted
for use in the UK [49] and updated [37].
Patients who consent to be contacted for the second
‘booster’ session will be contacted approximately 1 week
before surgery to arrange receipt. This will take place
either over the telephone or in clinic at the patient’s
preference. The HCP delivering the booster session will
complete the full AUDIT questionnaire with patients and
will aim to review or revise behavioural goals, provide
feedback on performance and discuss self-monitoring to
increase self-efficacy. The aim of the booster is to
reinforce behaviour change by providing an opportunity
for participants who had not set a goal or made a plan to
reduce their drinking in the initial session the opportunity
to do so. For those participants who had set a goal, the
booster offers an opportunity to reflect on their experi-
ences since the initial session, receive feedback on their
progress and revise or amend their goal if necessary. Such
sessions have previously been employed to address limita-
tions presented by busy clinical settings where clinician
time may be restricted and participants attention may be
elsewhere (such as on their medical care) [50]; however, as
booster sessions are not often well attended [51] and
findings regarding the added benefit of booster sessions
are mixed [52, 53], it was decided that these sessions
would be optional rather than required.
Comparator
Patients allocated to TAU will not receive the interven-
tion but will complete study baseline measures. As part
of the feasibility study, focus groups (N = 3) were con-
ducted with HCPs (total N = 19) from across the three
hospital sites to characterise TAU. As part of the
pre-assessment, all patients are asked about their alcohol
consumption. Questions cover whether the patient con-
sumes alcohol and, if so, aim to establish the number of
units consumed each week. Patients considered by the
preoperative assessment clinic nurse to be ‘heavy
drinkers’ or those identified through blood and/or liver
function tests are routinely referred to the consultant
anaesthetist for anaesthetic review to ensure patient
safety during anaesthesia.
Additionally, there is specialist support available for
patients to reduce or cease alcohol consumption at all
three participating centres. However, findings from the
focus groups identified that in the preoperative assess-
ment setting there is currently no standard process for
identifying and referring patients to these services with
identification being left to the judgement of the individ-
ual HCP. Further to this, referrals to these services from
Table 3 Schedule of enrolment, interventions and assessments
Time point Study period
Screening Visit 1
6–8 weeks
pre-surgery
Visit 2
1–2 weeks pre-surgery
(intervention arm only)
Visit 3
1 and 3 days
pre-surgery
Visit 4
Up to 5 days
post-surgery
Visit 5
6 weeks
post-surgery
Visit 6
6 months post
intervention
Enrolment:
AUDIT C X
Expression of Interest X
Consent X
Randomisation X
Interventions:
Intervention X
Booster X
TAU X
Assessments:
AUDIT Baseline X
EQ-5D Baseline X
AUDIT Outcome X X X X
EQ-5D Outcome X X
WOMAC X X
POMS X
Clavien-Dindo X
Interview X
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preoperative assessment HCPs were very low as a result of
a lack of knowledge regarding how to refer patients to
these services and, at one site, a requirement to ask pa-
tients if they wished to receive further support an offer
which staff reported patients consistently declined. While
leaflets about alcohol consumption were visibly available in
the waiting areas of the preoperative assessment clinics,
HCPs did not report routinely providing these to patients.
In addition, these are hospital-wide services, not specific to
the pre-assessment department and information or advice
is not delivered by preoperative assessment clinic staff.
Measures
The measures completed at each time point are displayed
in Table 3.
The primary feasibility outcomes of this pilot trial will
be the number of patients screened, and the percentages
of eligible patients recruited and retained at 6-month
follow-up. In addition to the study documentation
(AUDIT C screening questionnaires, expression of inter-
est and consent forms), detailed logs documenting each
patient approached and screened along with the out-
come of screening, expression of interest and consent
will be kept by each site and will be provided to the
NCTU on a monthly basis. A number of tools will assess
response variability in key measures proposed to be used
in a future definitive trial where the primary outcome
would be perioperative drinking status. Baseline alcohol
consumption, health-related quality of life and joint
functionality will be assessed by the full AUDIT [34],
EQ-5D and Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC) Functional Assessment
score [46] respectively. Changes in these measures will
be assessed with completion of the same measures at
follow-up (1–3 days pre-surgery (AUDIT only), 6 weeks
post-surgery and 6 months post intervention). Major
and minor postoperative complications will be recorded
by Clavien-Dindo classification [54] and the Postopera-
tive Morbidity Survey (POMS) [55] collected at 3–5 days
post-surgery.
Due to the low-risk nature of the study, adverse events
will not be recorded. All serious adverse events (SAEs)
excluding those which relate to pre-existing medical
conditions, planned rehospitalisation and postsurgical
complications which are covered by the trial outcome
measures (specifically Clavien-Dindo and POMS) will be
recorded by the PI or a delegate on a SAE form which
will be sent to the senior trial manager, trial manager,
chief investigator and the sponsor. For each SAE, full
details in medical terms and a case description will be
given along with the event duration, action taken, out-
come and seriousness criteria causality in the opinion of
the investigator and whether the event is considered
expected or unexpected. All safety data collected will be
reviewed by the Trial Steering Committee and Data
Monitoring Committee.
Follow-up
Baseline measures will be completed at the preoperative
assessment visit. Patients will be followed up 1–3 days pre-
operatively either by telephone or in hospital if admitted
the day before surgery; up to 5 days post-surgery while in
hospital; at the 6 weeks post-surgery outpatient appoint-
ment or by telephone; and 6 months post intervention.
Study data will be entered into the trial MACRO™
database. Access to the MACRO™ database will be
granted to site’s PIs, their delegated data entry personnel
at sites and NCTU trial management team for monitor-
ing purposes.
Qualitative work
Qualitative, in-depth, one-to-one semi-structured inter-
views will be conducted with both patient and HCP par-
ticipants. Patients who indicate at initial consent that they
would be happy to participate in a qualitative interview
will be asked again if they are willing to take part in an
interview as part of the 6-month post-intervention
follow-up. Patients still willing to participate in an inter-
view will be provided with an interview-specific informa-
tion sheet by email or post (dependent on patient
preference) at least 24 h before the interview is due to take
place. Following patient recruitment and intervention
delivery, HCPs involved in screening and/or intervention
delivery will also be invited to take part in a qualitative
interview. These interviews will be conducted by a
Research Associate (EL) and will use a semi-structured
topic guide to explore HCP and patient experiences of be-
ing involved in the trial, the acceptability of screening and
intervention tools/materials, barriers and facilitators to
screening and intervention delivery and the feasibility of
delivering screening and intervention in the preoperative
assessment clinic. Topic guides will include key questions
and prompts but will be left flexible enough for discussion
to include issues of importance to the participant or issues
arising from previous interviews. All interviews will be
digitally recorded, with consent, and transcribed verbatim.
Planned analysis
Statistical analysis
The measures collected at each time point are displayed
in Table 3. Analysis will be descriptive in nature. The
number of patients approached, screened, found to be
eligible and recruited (as documented in screening logs)
will be reported. Screening and eligibility rates will be
assessed.
The primary feasibility outcome is recruitment and re-
tention to 6-month follow-up. Systematic reviews and
meta-analyses of alcohol brief intervention trials show
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that follow-up rates vary with mean follow-up rates of
approximately 75% [56, 57] though rates of follow-up for
older adult populations may be higher (e.g. [58]). It was
therefore decided to allow for a loss to follow-up of 25%.
Based on current recommendations for external pilot
trials [59], 30 patients per arm at 6-month follow-up
were required to estimate the critical parameters to the
necessary degree of precision with a continuous primary
outcome. The pilot trial will therefore aim to obtain data
from 40 participants in each trial arm at baseline. As
follow-up rates vary between trials of alcohol brief inter-
ventions, the target recruitment sample size will be kept
under review, and recruitment will cease when we esti-
mate that 60 patients will provide data at 6 months post
intervention.
Secondary outcomes of compliance with randomisa-
tion (whether or not participants received the interven-
tion when randomised to the intervention condition),
and data completion of baseline measures will also be
reported. Non-completers will be characterised.
The pilot feasibility trial will also assess performance
of potential outcome measures for a definitive trial. We
will ascertain data completeness of the study tools and
any potential bias in the completion of follow-up data
(assessing if completion rates on each clinical outcome
are markedly different in either trial arm), to inform the
choice of tools for a future trial.
The majority of data will be presented in simple de-
scriptive tables presenting percentages, means and
standard deviations or five-number summary (the mini-
mum, first quartile, median, third quartile, and max-
imum) as appropriate, for each arm of the study. This
information will be used to inform the design, choice of
primary outcome, necessary sample size and approach
to the analysis, of the future definitive trial.
Qualitative analysis
Qualitative data from HCP and patient interviews will be
used to assess the acceptability of screening, intervention
and research methods. Anonymised transcripts will be
analysed using Framework analysis [60]. This is a recom-
mended approach for qualitative health research with
objectives linked to quantitative investigation [61]. NVivo
software will be used to aid indexing and charting. The
data will be repeatedly read and coded independently by
two researchers (EL, KH) within a framework of a priori is-
sues and those identified by participants (patients or HCPs)
or emerging from the data. Any divergence between coders
will be discussed on an on-going basis to inform the ana-
lysis and resolve divergence in their interpretations of the
data. Analysis will be discussed at regular meetings of the
research team to identify areas for closer consideration
(including negative case analysis) and to enhance credibil-
ity of the thematic framework and interpretation [61, 62].
Framework analysis of the qualitative data will explore
influences on patient recruitment, implementation, receipt
of the study interventions and data collection methods.
Analysis of the likelihood of embedding study interven-
tions in clinical practice (HCP data) will be informed by
Normalisation Process Theory [63]. This model considers
factors that affect implementation in four key areas; how
people make sense of a new practice (coherence); the
willingness of people to sign-up and commit to the new
practice (cognitive participation); their ability to take on
the work required of the practice (collective action); and
activity undertaken to monitor and review the practice
(reflexive monitoring). The approach is increasingly used
in studies of the implementation of interventions in health
care (www.normalizationprocess.org). Analysis will con-
sider how well the behavioural intervention is introduced
and incorporated for both patients and HCPs.
Fidelity analyses
Consultations with a participating patient will be audio
recorded to allow an assessment of skill acquisition and
fidelity of delivery post-training. Audio recordings will
be transcribed verbatim. A Research Associate (EL)
trained in the use of the Behaviour Change Taxonomy
Version 1 (BCT v1) and an expert coder (LA) will inde-
pendently code all consultation transcripts to assess skill
acquisition (for feedback purposes) and fidelity of deliv-
ery of each specific BCT. A coding frame/fidelity check-
list based on the BCTv1 will be used to identify whether
each BCT was delivered faithfully as planned. Where
discrepancies in coding exist, the RA and expert coder
will meet to resolve these via discussion. The percentage
of positive agreement will be calculated to assess
inter-rater reliability.
Monitoring, audit and inspection
Monitoring will be performed by a combination of cen-
tral review and site monitoring visits and external Data
Monitoring Committee to ensure the study is conducted
in accordance with GCP. Study site monitoring will be
undertaken by Newcastle Clinical Trial Unit. The main
areas of focus will include consent, serious adverse
events, data completeness and accuracy and essential
documents in study. The trial may be subject to audit by
representatives of the Sponsor. Each investigator site will
permit trial-related monitoring, audits and regulatory
inspection including access to all essential and source
data relating to the trial.
Data will be analysed by the Trial Statisticians and re-
ported to an external independent DMC at least annually.
Discussion
Existing research demonstrates the benefit of clinics
dedicated to preoperative assessment [64] and a growing
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body of evidence points to the additional gains that can
be made through implementation of prehabilitation
targeting modifiable factors including physical activity,
nutrition and smoking cessation [28, 65, 66]. Increased
preoperative alcohol consumption is associated with an
increased risk of postoperative complications [1, 2] thus
interventions which reduce preoperative alcohol con-
sumption may be one method of reducing surgical risk
[3, 30]. While previous work has identified that alcohol
screening and brief intervention is effective in other
settings, especially primary care [36, 37], little is known
about the feasibility of delivering these techniques in
the preoperative setting. Significant uncertainties mean
that proceeding immediately to a definitive trial would
be a high risk.
Three key factors which restricted initial recruitment
were identified and addressed during the feasibility work.
Firstly, a number of patients demonstrated adverse
responses to the term ‘risky drinking’ which previously
appeared in the study title and documentation, this was
amended so that wording focuses on the benefits of
reducing alcohol consumption. Secondly, screening re-
activity resulted in reductions in reported alcohol con-
sumption at baseline, prior to confirmation in eligibility
and meant that the number of patients who screened
eligible, consented to the study, but did not go on to
receive the intervention was higher than anticipated. For
this reason eligibility for the RCT will be based on the
initial screening score with later measures employed to
track changes in alcohol consumption over the study
period. Finally, allowing the patient too long to consider
involvement in the study before obtaining ongoing ex-
pression of interest hindered the facilitation and organ-
isation of intervention sessions, especially when patients
were not contactable on the first attempt, and led to
many patients forgetting about the study. Allowing pa-
tients a minimum of 24 h to consider their involvement
means that the study information is fresh in their minds
and facilitates effective coordination of preoperative as-
sessment and intervention delivery. Further operational
issues, specifically the availability of physical space and
staff time in the clinics, were also identified but could
not be fully addressed within the scope of this study as
this would require a significant increase in financial and
human resources. Further to this, obtaining research
participation without an impact on patient care could be
difficult if there is a temporary reduction in staff levels
through sickness or absence, something which cannot be
controlled. However, the pilot RCT implemented some
strategies to reduce the impact of these issues. The bur-
den on staff time and need for physical space to conduct
study activities were reduced as much as possible by
having research-specific activities (e.g. consent, random-
isation 6-month follow-up) conducted by research rather
than clinical staff and allowing screening and follow-up
measures to be collected over the telephone rather than in
person. In addition a ‘coping planning’ element was in-
cluded in the revised HCP training and training manual.
This provided specific examples of difficulties encountered
during the feasibility trial and encouraged HCPs to
pre-plan methods of coping should they encounter these
difficulties (e.g. being short on time) as well as providing
suggested coping methods if they could not come up with
their own. The ongoing impact and potential mechanisms
for overcoming these difficulties will be considered in the
qualitative interviews with HCPs.
Quantitative findings will investigate the recruitment
and retention of patient participants, comparing these to
target rates as well as completion rates of planned out-
come measures employed. This will allow conclusions
about the feasibility of proceeding to a definitive RCT to
be drawn and an accurate sample size calculation for a
full RCT to be produced. Qualitative data and fidelity of
delivery assessments from this pilot RCT will be used to
further optimise intervention materials and methods,
and to establish the acceptability of screening, interven-
tion and research methods. In addition to informing a
future definitive RCT this work may act as a model of
risk reduction interventions targeting other health be-
haviours associated with post-operative complications
such as smoking and physical activity.
Current status of study
The trial commenced recruitment in July 2017.
Abbreviations
AUDIT: Alcohol Use Disorders Identification Tool; BA: Brief Advice;
BCT: Behaviour change technique; BI: Brief Intervention; CI: Confidence
intervals; HCP: Healthcare professional; NCTU: Newcastle Clinical Trials Unit;
OR: Odds ratio; PAC: Preoperative assessment clinic; POMS: Postoperative
Morbidity Survey; RA: Research Associate; RCT: Randomised controlled trial;
TAU: Treatment as usual; WOMAC: Western Ontario McMaster Universities
Osteoarthritis Index
Acknowledgements
This is an outline of research managed by the Newcastle Clinical Trials Unit
and funded by the National Institute of Health Research Health Technology
Assessment. The views expressed are those of the author(s) and not
necessarily those of the NHS, the NIHR or the Department of Health.
Funding
PRE-OP BIRDS is funded by the National Institute for Health Research Health
Technology Assessment. Funder Reference: 14/42/01. Trial registration
number ISRCTN: 36257982.
Authors’ contributions
All authors have made an intellectual contribution to this research trial. CS,
EK, LA, CH, CG, DH, JP, EG and EM are co-applicants and are responsible for
designing the research. EL wrote the draft of the paper and all authors have
had input into drafts, have read and approved the final version of the
manuscript. CS is the principal investigator for the PRE-OP BIRDS Pilot Trial.
EK, LA and EL have responsibility for intervention development and adaptation.
DH and ES have responsibility for statistical considerations. KH has responsibility
for qualitative considerations. CS, CG and JP are responsible for clinical consider-
ations. NG, NH and LH have been responsible for the management of the trial
by Newcastle Clinical Trials Unit.
Snowden et al. Pilot and Feasibility Studies  (2018) 4:140 Page 11 of 13
Ethics approval and consent to participate
This study was approved by the North East – Tyne & Wear South Research
Ethics Committee on 04/04/2017 (17/NE/0093). Newcastle upon Tyne
Hospitals NHS Foundation Trust will act as the trial sponsor. The PRE-OP
BIRDS Trial Management Group will be responsible for ensuring the appropri-
ate and timely implementation of the trial. A Trial Steering Committee and
Data Monitoring Committee have been appointed to oversee the trial with a
focus on recruitment, retention, adherence to trial protocol and participant
safety. Informed consent will be explained verbally to patients and HCPs
who will consent via written signature.
Consent for publication
Not applicable
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1The Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman
Hospital, Freeman Road, Newcastle upon Tyne NE7 7DN, UK. 2Institute of
Health & Society, Newcastle University, Baddiley-Clark, Richardson Road,
Newcastle upon Tyne NE2 4AX, UK. 3Institute of Cellular Medicine, 4th Floor,
William Leech Building, Medical School, Newcastle University, Newcastle
upon Tyne NE2 4HH, UK. 4Newcastle Addictions Service, Northumberland
Tyne and Wear NHS Foundation Trust, Plummer Court, Carliol Square,
Newcastle upon Tyne NE1 6UR, UK. 5Newcastle Clinical Trials Unit, Newcastle
University, 1-4 Claremont Terrace, Newcastle upon Tyne NE2 4AE, UK.
6Department of Social Work, Education & Community Wellbeing,
Northumbria University, Room B125, Coach Lane Campus West, Newcastle
upon Tyne NE7 7XA, UK.
Received: 31 August 2017 Accepted: 5 August 2018
References
1. Oppedal K, Møller AM, Pedersen B, et al. Preoperative alcohol cessation
prior to elective surgery. Cochrane Database Syst Rev. 2012;7. https://doi.
org/10.1002/14651858.CD008343.pub2.
2. Eliasen M, Grønkjær M, Skov-Ettrup LS, et al. Preoperative alcohol
consumption and postoperative complications: a systematic review and
meta-analysis. Ann Surg. 2013;258(6):930–42.
3. Harris AHS, Reeder R, Ellerbe L, et al. Preoperative alcohol screening scores:
association with complications in men undergoing total joint arthroplasty. J
Bone Joint Surg Am. 2011;93(4):321–7.
4. Rotevatn TA, Bøggild H, Olesen CR, et al. Alcohol consumption and the risk
of postoperative mortality and morbidity after primary hip or knee
arthroplasty—a register-based cohort study. PLoS One. 2017;12(3):e0173083.
5. Khuri SF, Henderson WG, DePalma RG, et al. Determinants of long-term
survival after major surgery and the adverse effect of postoperative
complications. Ann Surg. 2005;242(3):326–43.
6. Abbott TEF, Fowler AJ, Dobbs TD, et al. Frequency of surgical treatment and
related hospital procedures in the UK: a national ecological study using
hospital episode statistics. Br J Anaesth. 2017;119(2):249–57.
7. Lawrence VA, Hazuda HP, Cornell JE, et al. Functional independence
after major abdominal surgery in the elderly. J Am Coll Surg. 2004;
199(5):762–72.
8. Moonesinghe SR, Harris S, Mythen MG, et al. Survival after postoperative
morbidity: a longitudinal observational cohort study. Br J Anaesth. 2014;
113(6):977–84.
9. Belmont PJ Jr, Goodman GP, Waterman BR, et al. Thirty-day
postoperative complications and mortality following total knee
arthroplasty: incidence and risk factors among a national sample of
15,321 patients. JBJS. 2014;96(1):20–6.
10. Hunt LP, Ben-Shlomo Y, Clark EM, et al. 90-day mortality after 409 096
total hip replacements for osteoarthritis, from the National Joint
Registry for England and Wales: a retrospective analysis. Lancet. 2013;
382(9898):1097–104.
11. Hunt LP, Ben-Shlomo Y, Clark EM, et al. 45-day mortality after 467 779
knee replacements for osteoarthritis from the National Joint Registry for
England and Wales: an observational study. Lancet. 2014;384(9952):
1429–36.
12. Inneh IA, Lewis CG, Schutzer SF. Focused risk analysis: regression model
based on 5,314 total hip and knee arthroplasty patients from a single
institution. J Arthroplast. 2014;29(10):2031–5.
13. (HSCIC) HaSCIC. Hospital Episode statistics 2013/2014; 2015.
14. Lloyd-Sherlock P, McKee M, Ebrahim S, et al. Population ageing and health.
Lancet. 2012;379(9823):1295–6.
15. Divo MJ, Martinez CH, Mannino DM. Ageing and the epidemiology of
multimorbidity. Eur Respiratory Soc. 2014;44(4):1055–68.
16. Pearse RM, Moreno RP, Bauer P, et al. Mortality after surgery in Europe: a 7
day cohort study. Lancet. 2012;380(9847):1059–65.
17. Findlay G, Goodwin A, Protopapa K, et al. Knowing the risk; a review of the
peri-operative care of surgical patients. London: National Confidential
Enquiry into Patient Outcome and Death; 2011.
18. Rose J, Weiser TG, Hider P, et al. Estimated need for surgery worldwide
based on prevalence of diseases: implications for public health planning of
surgical services. Lancet Glob Health. 2015;3(Suppl 2):S13.
19. Cook JR, Warren M, Ganley KJ, et al. A comprehensive joint replacement
program for total knee arthroplasty: a descriptive study. BMC Musculoskelet
Disord. 2008;9(1):154.
20. Goodnough LT, Maniatis A, Earnshaw P, et al. Detection, evaluation, and
management of preoperative anaemia in the elective orthopaedic surgical
patient: NATA guidelines. Br J Anaesth. 2011;106(1):13–22.
21. Kothmann E, Batterham AM, Owen SJ, et al. Effect of short-term exercise
training on aerobic fitness in patients with abdominal aortic aneurysms: a
pilot study. Br J Anaesth. 2009;103(4):505–10.
22. Tew GA, Moss J, Crank H, et al. Endurance exercise training in patients with
small abdominal aortic aneurysm: a randomized controlled pilot study. Arch
Phys Med Rehabil. 2012;93(12):2148–53.
23. Topp R, Swank AM, Quesada PM, et al. The effect of prehabilitation
exercise on strength and functioning after total knee arthroplasty.
PM&R. 2009;1(8):729–35.
24. Santa Mina D, Clarke H, Ritvo P, et al. Effect of total-body prehabilitation on
postoperative outcomes: a systematic review and meta-analysis.
Physiotherapy. 2014;100(3):196–207.
25. Carli F, Charlebois P, Baldini G, et al. An integrated multidisciplinary
approach to implementation of a fast-track program for laparoscopic
colorectal surgery. Can J Anesth. 2009;56(11):837–42.
26. Carli F, Scheede-Bergdahl C. Prehabilitation to enhance perioperative care.
Anesthesiol Clin. 2015;33(1):17–33.
27. Grocott MPW, Mythen MG. Perioperative medicine: the value
proposition for anesthesia?: a UK perspective on delivering value from
anesthesiology. Anesthesiol Clin. 2015;33(4):617–28.
28. Musallam KM, Rosendaal FR, Zaatari G, et al. Smoking and the risk of
mortality and vascular and respiratory events in patients undergoing major
surgery. JAMA Surg. 2013;148(8):755–62.
29. Best MJ, Buller LT, Gosthe RG, et al. Alcohol misuse is an independent risk
factor for poorer postoperative outcomes following primary total hip and
total knee arthroplasty. J Arthroplast. 2015;30(8):1293–8.
30. Bradley KA, Rubinsky AD, Sun H, et al. Alcohol screening and risk of
postoperative complications in male VA patients undergoing major non-
cardiac surgery. J Gen Intern Med. 2011;26(2):162–9.
31. Wilson GB, Wray C, McGovern R, et al. Intervention to reduce excessive
alcohol consumption and improve comorbidity outcomes in hypertensive
or depressed primary care patients: two parallel cluster randomized
feasibility trials. Trials. 2014;15(1):235.
32. Poon A, Owen J, Gijsbers AJ. Identification of at-risk drinkers in an
orthopaedic inpatient population. ANZ J Surg. 1994;64(11):775–9.
33. Shourie S, Shourie S, Conigrave KM, et al. Pre-operative screening for
excessive alcohol consumption among patients scheduled for elective
surgery. Drug Alcohol Rev. 2007;26(2):119–25.
34. Saunders JB, Aasland OG, Babor TF, et al. Development of the alcohol use
disorders identification test (AUDIT): WHO collaborative project on early
detection of persons with harmful alcohol consumption-II. Addiction. 1993;
88(6):791–804.
35. Kip MJ, Neumann T, Jugel C, et al. New strategies to detect alcohol use
disorders in the preoperative assessment clinic of a German university
hospital. J Am Soc Anesthesiol. 2008;109(2):171–9.
Snowden et al. Pilot and Feasibility Studies  (2018) 4:140 Page 12 of 13
36. Kaner EF, Beyer F, Dickinson HO, et al. Effectiveness of brief alcohol
interventions in primary care populations. Cochrane Database Syst Rev.
2007;2. https://doi.org/10.1002/14651858.CD004148.pub3.
37. Kaner E, Bland M, Cassidy P, et al. Effectiveness of screening and brief
alcohol intervention in primary care (SIPS trial): pragmatic cluster
randomised controlled trial. BMJ. 2013;346:e8501.
38. Kaner E, Beyer, FR, Muirhead, C, Campbell, F, Pienaar, ED, Bertholet, N,
Daeppen, J, Saunders, JB, Burnand, B. Effectiveness of brief alcohol
interventions in primary care populations. Cochrane Database Syst Rev.
2018(Issue 2.):Art. No.: CD004148.
39. Beyer F, Lynch E, Kaner E. Brief interventions in primary care: an evidence
overview of practitioner and digital intervention programmes. Curr Addict
Rep. 2018;5(2):265–73.
40. Blow FC, Barry KL, Walton MA, et al. The efficacy of two brief
intervention strategies among injured, at-risk drinkers in the emergency
department: impact of tailored messaging and brief advice. J Stud
Alcohol. 2006;67(4):568–78.
41. Rosenberg J, Nielsen HJ, Rasmussen V, et al. Effect of preoperative
abstinence on poor postoperative outcome in alcohol misusers: randomised
controlled trial. BMJ. 1999;318(7194):1311–6.
42. McQueen J, Howe TE, Allan L, et al. Brief interventions for heavy alcohol
users admitted to general hospital wards. Cochrane Database Syst Rev.
2011;8(8). https://doi.org/10.1002/14651858.CD005191.pub3.
43. Shourie S, Conigrave KM, Proude EM, et al. The effectiveness of a tailored
intervention for excessive alcohol consumption prior to elective surgery.
Alcohol Alcohol. 2006;41(6):643–9.
44. Brooks R, Group E. EuroQol: the current state of play. Health Policy. 1996;
37(1):53–72.
45. Herdman M, Gudex C, Lloyd A, et al. Development and preliminary
testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res.
2011;20(10):1727–36.
46. Dowsey MM, Choong PFM. The utility of outcome measures in total knee
replacement surgery. Int J Rheumatol. 2013;2013:506518.
47. Coulton S, Perryman K, Bland M, et al. Screening and brief interventions for
hazardous alcohol use in accident and emergency departments: a
randomised controlled trial protocol. BMC Health Serv Res. 2009;9(1):114.
48. Centre for Drug and Alcohol Studies. The Drink-Less Programme; 1993.
49. McAvoy B, Kaner E, Haighton K, et al. Drink-Less. Marketing a brief
intervention package in UK general practice. Fam Pract. 1997;14:427–8.
50. Longabaugh R, Woolard RE, Nirenberg TD, et al. Evaluating the effects of a
brief motivational intervention for injured drinkers in the emergency
department. J Stud Alcohol. 2001;62(6):806–16.
51. Baird J, Longabaugh R, Lee CS, et al. Treatment completion in a brief
motivational intervention in the emergency department: The effect of
multiple interventions and therapists’ behavior. Alcohol Clin Exp Res. 2007;
31:71s–5s.
52. Fleming MF, Mundt MP, French MT, et al. Brief physician advice for problem
drinkers: long-term efficacy and benefit-cost analysis. Alcohol Clin Exp Res.
2002;26(1):36–43.
53. Kaner EFS, Dickinson HO, Beyer F, et al. The effectiveness of brief alcohol
interventions in primary care settings: a systematic review. Drug Alcohol
Rev. 2009;28(3):301–23.
54. Dindo D, Demartines N, Clavien P-A. Classification of surgical complications:
a new proposal with evaluation in a cohort of 6336 patients and results of a
survey. Ann Surg. 2004;240(2):205–13.
55. Grocott MPW, Browne JP, Van der Meulen J, et al. The postoperative
morbidity survey was validated and used to describe morbidity after major
surgery. J Clin Epidemiol. 2007;60(9):919–28.
56. Wilk AI, Jensen NM, Havighurst TC. Meta-analysis of randomized control
trials addressing brief interventions in heavy alcohol drinkers. J Gen Intern
Med. 1997;12(5):274–83.
57. Bertholet N, Daeppen J-B, Wietlisbach V, et al. Reduction of alcohol
consumption by brief alcohol intervention in primary care: systematic
review and meta-analysis. Arch Intern Med. 2005;165(9):986–95.
58. Fleming MF, Manwell LB, Barry KL, et al. Brief physician advice for alcohol
problems in older adults: a randomized community-based trial. J Fam Pract.
1999;48:378–86.
59. Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies:
recommendations for good practice. J Eval Clin Pract. 2004;10(2):307–12.
60. Srivastava A, Thomson SB. Framework analysis: a qualitative methodology
for applied policy research. 2009.
61. Pope C, Ziebland S, Mays N. Analysing qualitative data. Br Med J. 2000;
320(7227):114.
62. Schlosser R. On the importance of being earnest about treatment integrity.
Augment Altern Commun. 2002;18(1):36–44.
63. May CR, Finch T, Ballini L, et al. Evaluating complex interventions and
health technologies using normalization process theory: development
of a simplified approach and web-enabled toolkit. BMC Health Serv Res.
2011;11(1):245.
64. Snowden CP, Anderson H. Preoperative optimization: rationale and process:
is it economic sense? Curr Opin Anesthesiol. 2012;25(2):210–6.
65. Fearon KC, Jenkins JT, Carli F, et al. Patient optimization for gastrointestinal
cancer surgery. Br J Surg. 2013;100(1):15–27.
66. Durrand JW, Batterham AM, Danjoux GR. Pre-habilitation (i): aggregation of
marginal gains. Anaesthesia. 2014;69(5):403–6.
Snowden et al. Pilot and Feasibility Studies  (2018) 4:140 Page 13 of 13
